Clinical Case Series - 24cart - Question 2

What barriers, if any, have you encountered regarding the reality of getting patients to second-line CAR T-cell therapy? (Select all that apply.)

Medical ineligibility
Insurance barriers
Financial cost
Time from selection to administration
Access to CAR T-cell infusion center
CAR T-cell product availability
Patient concerns about CAR T-cell therapy-related toxicities (e.g., CRS, ICANS)
{"name":"Clinical Case Series - 24cart - Question 2", "url":"https://www.poll-maker.com/QL3VERRHJ","txt":"What barriers, if any, have you encountered regarding the reality of getting patients to second-line CAR T-cell therapy? (Select all that apply.)","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys